The study also explored possible regulatory effects of anti-VEGF agents on selected target genes in the retina and choroid involved in angiogenesis, inflammation, vascular permeability and edema, as well as known factors involved in retinal disorders such as nAMD, DME, and RVO. Here, VEGFA is linked to retinal disorder.